StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $33 at Goldman Sachs
October 30, 2024 6:16 AM
Goldman Sachs analyst Chris Shibutani raised the price target on Pfizer (NYSE: PFE) to $33.00 (from $32.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Popular stocks with increasing volume: SOFI DJT F PFE BA MSTR PYPL SMCI SNAP GME
October 30, 2024 4:46 AM
Pfizer (PFE) Meeting With Starboard Was Constructive, Cordial - CEO Bourla
October 29, 2024 10:39 AM
Form 8-K PFIZER INC For: Oct 29
October 29, 2024 8:07 AM
Pfizer raises full-year guidance, beats Q3 estimates; shares climb
October 29, 2024 7:16 AM
Pfizer CEO defends turnaround strategy as activist pressures management
October 29, 2024 6:55 AM
Pfizer (PFE) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY24 Guidance
October 29, 2024 6:46 AM
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
October 29, 2024 6:45 AM
Pfizer (PFE) call put ratio 3.7 calls to 1 put with focus on November 1 weekly calls into quarter results
October 28, 2024 10:35 AM
Pfizer (PFE) call put ratio 3.2 calls to 1 put into quarter results
October 28, 2024 5:45 AM
